SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BBIO

BridgeBio Pharma, Inc.
NASDAQHealth Care

Latest close: 66.39 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 17, 2026Reported sale · Form 4Neil Kumar, Chief Executive Officer · $601.9KOpen the filing ↗
  3. Sep 17, 2026Reported sale · Form 4Neil Kumar, Chief Executive Officer · $89.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record79824 flagged findings
Reported transactions (Form 4)80since Dec 12, 2025 · and 11 other holdings
Corporate events (8-K)30since Dec 6, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-08share offering or dilution eventrecentOpen filing ↗
    “…1933, as amended (the “Securities Act”) with the Securities and Exchange Commission . In addition, on May 7, 2026, the Company…”
  • 2026-05-08share offering or dilution eventrecentOpen filing ↗
    “…a combination of any of these methods. If underwriters or dealers are used in the sale, the securities will be acquired by the…”
    +1 more passage from the same document
    • “…the 2019 Employee Stock Purchase Plan pursuant to evergreen increase provisions; • 583,425 shares of our common stock reserved for…”
  • 2026-05-08capital return (buybacks/dividends)recentOpen filing ↗
    “…expenses; and other general corporate purposes. We may also use net proceeds to fund potential acquisitions of, or investments…”
    +1 more passage from the same document
    • “…the potential commercialization of our product candidates, if approved; working capital; capital expenditures; debt repayment;…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 798)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 268-K ↗Current report · Other events new
  • Sep 21, 26Form 4 ↗Insider transaction
  • Aug 31, 268-K ↗Current report · Other events
  • Aug 20, 26Form 4 ↗Insider transaction
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Aug 17, 26Form 144 ↗Notice of proposed sale
  • Aug 17, 26SCHEDULE 13D/A ↗Stake with intent to influence · KKR Group Partnership L.P. · 4.7% · event on Aug 13, 26 · amendment
  • Aug 17, 268-K ↗Current report · Entered a material agreement
  • Aug 14, 26424B7 ↗Securities offering
  • Aug 10, 2610-Q ↗Quarterly report
  • Aug 10, 268-K ↗Current report · Results
  • Aug 3, 26Form 4 ↗Insider transaction
  • Aug 3, 26SCHEDULE 13G/A ↗Passive stake · Farallon Capital Management, L.L.C. · 5.5% · event on Jun 30, 26 · amendment
  • Jul 27, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 5.0% · event on Jun 30, 26 · amendment
  • Jul 24, 26S-3ASR ↗Securities offering
  • Jul 22, 268-K ↗Current report · Other events
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jul 10, 26SCHEDULE 13D/A ↗Stake with intent to influence · VIKING GLOBAL INVESTORS LP · 5.0% · event on Jul 9, 26 · amendment
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide

798 filings on record, the oldest from Jun 19, 18.

Listing the 25 most recent filings of the 798 on record.

8-Ks, explained

Structure53Governance13
  • Aug 17, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 2, 26StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Jun 26, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2025 – 2026show all 3hide
    • May 8, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jan 21, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Jul 2, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Mar 17, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 28, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Aug 21, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 23, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure6 material agreements entered2023 – 2024show all 6hide
    • Mar 6, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 4, 24StructureEntered a material agreement8-K 1.01 ↗
    • Jan 18, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Sep 25, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • May 4, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 9, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 23, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Dec 6, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

The record reaches back to Sep 12, 19.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • HALVORSEN OLE ANDREAS9.7%Aug 14, 25SCHEDULE 13D/A ↗14 co-filers on this document — the figure is the largest single stake, not their sum.
  • KKR Genetic Disorder L.P.7.0%May 12, 25SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • VIKING GLOBAL INVESTORS LP5.0%Jul 9, 26SCHEDULE 13D/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 6 earlier filings
  • KKR Group Partnership L.P.4.7%Aug 13, 26SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • The Vanguard Group8.7%Jun 30, 25SCHEDULE 13G/A ↗
  • JANUS HENDERSON GROUP PLC6.8%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
  • Farallon Capital Management, L.L.C.5.5%Jun 30, 26SCHEDULE 13G/A ↗29 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dapice Joshua J.5.2%May 22, 26SCHEDULE 13G ↗28 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.0%Jun 30, 26SCHEDULE 13G/A ↗
show 2 more holdershide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 19, KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 filed notice of intent to sell up to $2.5M. That is about 0.02% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.5M across 5 trades, between Aug 19 and Sep 17, per their Form 4. That is 67% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 7 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 17, 26Sell$602KNeil KumarChief Executive Officer↗
  • Sep 17, 26Sell$89KNeil KumarChief Executive Officer↗
  • Aug 19, 26Sell$679KNeil KumarChief Executive Officer↗
  • Aug 19, 26Sell$152KNeil KumarChief Executive Officer↗
  • Aug 19, 26Sell$9KNeil KumarChief Executive Officer↗
  • Aug 18, 26Sell$154KNeil KumarChief Executive Officer↗
  • Aug 18, 26Sell$1.4MNeil KumarChief Executive Officer↗
  • Aug 18, 26Sell$1.2MNeil KumarChief Executive Officer↗
  • Aug 18, 26Sell$100KNeil KumarChief Executive Officer↗
  • Jul 30, 26Sell$160KMaricel ApuliChief Accounting Officer↗
  • Jul 9, 26Sell$3.0MJennifer E. Cook↗
  • Jul 9, 26Sell$10.1MJennifer E. Cook↗

There are 4 more transactions in this stretch.

Stock compensation, tax and giftsshow the 24 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 16, 26Tax$376KMaricel ApuliChief Accounting Officer↗
  • Aug 16, 26Compensationamount n/aNeil KumarChief Executive Officer↗
  • Aug 16, 26Compensationamount n/aNeil KumarChief Executive Officer↗
  • Aug 16, 26Compensationamount n/aNeil KumarChief Executive Officer↗
  • Aug 16, 26Compensationamount n/aNeil KumarChief Executive Officer↗
  • Aug 16, 26Tax$2.9MNeil KumarChief Executive Officer↗
  • Aug 16, 26Tax$1.8MThomas TrimarchiPresident and CFO↗
  • Jul 9, 26Compensation$161KJennifer E. Cook↗
  • Jul 9, 26Compensation$3.3MJennifer E. Cook↗
  • Jul 9, 26Compensation$288KJennifer E. Cook↗
  • Jul 9, 26Compensation$288KAndrea Ellis↗
  • Jun 24, 26Compensation$169KJennifer E. Cook↗
  • Jun 24, 26Compensation$288KJennifer E. Cook↗
  • Jun 22, 26Compensationamount n/aAli J. Satvat↗
  • Jun 22, 26Compensationamount n/aDouglas A. Dachille↗
  • Jun 22, 26Compensationamount n/aFRANK MCCORMICK↗
  • Jun 22, 26Compensationamount n/aJAMES C MOMTAZEE↗
  • Jun 22, 26Compensationamount n/aFred Hassan↗
  • Jun 22, 26Compensationamount n/aAndrea Ellis↗
  • Jun 22, 26Compensationamount n/aRONALD J DANIELS↗
  • Jun 22, 26Compensationamount n/aERIC AGUIAR↗
  • Jun 22, 26Compensationamount n/aCHARLES J HOMCY↗
  • Jun 22, 26Compensationamount n/aAndrew Lo↗
  • Jun 22, 26Compensationamount n/aHannah Valantine↗

The full record holds 433 transactions and goes back to Nov 16, 21.

Its sector and its market

BridgeBio Pharma, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From BridgeBio Pharma, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow BridgeBio Pharma, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
798 documents on file, from Jun 19, 2018 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.